nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—ABCB1—epilepsy syndrome	0.176	1	CbGaD
Indacaterol—UGT1A1—Propofol—epilepsy syndrome	0.0986	0.18	CbGbCtD
Indacaterol—ABCB1—Levetiracetam—epilepsy syndrome	0.0407	0.0743	CbGbCtD
Indacaterol—ABCB1—Clobazam—epilepsy syndrome	0.0282	0.0515	CbGbCtD
Indacaterol—ABCB1—Lamotrigine—epilepsy syndrome	0.0271	0.0496	CbGbCtD
Indacaterol—ABCB1—Carbamazepine—epilepsy syndrome	0.0234	0.0427	CbGbCtD
Indacaterol—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0223	0.0407	CbGbCtD
Indacaterol—ABCB1—Phenytoin—epilepsy syndrome	0.021	0.0383	CbGbCtD
Indacaterol—CYP3A4—Felbamate—epilepsy syndrome	0.0207	0.0379	CbGbCtD
Indacaterol—CYP3A4—Trimethadione—epilepsy syndrome	0.0207	0.0379	CbGbCtD
Indacaterol—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0195	0.0356	CbGbCtD
Indacaterol—ABCB1—Phenobarbital—epilepsy syndrome	0.0187	0.0341	CbGbCtD
Indacaterol—ABCB1—Midazolam—epilepsy syndrome	0.0184	0.0336	CbGbCtD
Indacaterol—ABCB1—Diazepam—epilepsy syndrome	0.0177	0.0323	CbGbCtD
Indacaterol—CYP3A4—Clonazepam—epilepsy syndrome	0.0176	0.0322	CbGbCtD
Indacaterol—CYP3A4—Clobazam—epilepsy syndrome	0.0169	0.0309	CbGbCtD
Indacaterol—CYP3A4—Rufinamide—epilepsy syndrome	0.0144	0.0262	CbGbCtD
Indacaterol—CYP3A4—Carbamazepine—epilepsy syndrome	0.014	0.0256	CbGbCtD
Indacaterol—CYP3A4—Primidone—epilepsy syndrome	0.0131	0.0239	CbGbCtD
Indacaterol—CYP3A4—Phenytoin—epilepsy syndrome	0.0126	0.0229	CbGbCtD
Indacaterol—CYP3A4—Propofol—epilepsy syndrome	0.0117	0.0214	CbGbCtD
Indacaterol—CYP3A4—Acetazolamide—epilepsy syndrome	0.0112	0.0204	CbGbCtD
Indacaterol—CYP3A4—Phenobarbital—epilepsy syndrome	0.0112	0.0204	CbGbCtD
Indacaterol—CYP3A4—Midazolam—epilepsy syndrome	0.011	0.0202	CbGbCtD
Indacaterol—CYP3A4—Diazepam—epilepsy syndrome	0.0106	0.0194	CbGbCtD
Indacaterol—CYP3A4—Zonisamide—epilepsy syndrome	0.0104	0.0189	CbGbCtD
Indacaterol—CYP3A4—Valproic Acid—epilepsy syndrome	0.00836	0.0153	CbGbCtD
Indacaterol—CYP3A4—Topiramate—epilepsy syndrome	0.00755	0.0138	CbGbCtD
Indacaterol—Headache—Clobazam—epilepsy syndrome	0.000233	0.00119	CcSEcCtD
Indacaterol—Immune system disorder—Valproic Acid—epilepsy syndrome	0.000233	0.00119	CcSEcCtD
Indacaterol—Tachycardia—Carbamazepine—epilepsy syndrome	0.000232	0.00119	CcSEcCtD
Indacaterol—Dyspnoea—Zonisamide—epilepsy syndrome	0.000232	0.00119	CcSEcCtD
Indacaterol—Nasopharyngitis—Topiramate—epilepsy syndrome	0.000232	0.00119	CcSEcCtD
Indacaterol—Mediastinal disorder—Valproic Acid—epilepsy syndrome	0.000232	0.00119	CcSEcCtD
Indacaterol—Skin disorder—Carbamazepine—epilepsy syndrome	0.000231	0.00119	CcSEcCtD
Indacaterol—Oedema peripheral—Pregabalin—epilepsy syndrome	0.000229	0.00118	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000229	0.00117	CcSEcCtD
Indacaterol—Connective tissue disorder—Pregabalin—epilepsy syndrome	0.000229	0.00117	CcSEcCtD
Indacaterol—Infection—Lamotrigine—epilepsy syndrome	0.000229	0.00117	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.000227	0.00117	CcSEcCtD
Indacaterol—Nausea—Lacosamide—epilepsy syndrome	0.000227	0.00117	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000226	0.00116	CcSEcCtD
Indacaterol—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000226	0.00116	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000225	0.00115	CcSEcCtD
Indacaterol—Tachycardia—Lamotrigine—epilepsy syndrome	0.000225	0.00115	CcSEcCtD
Indacaterol—Asthma—Topiramate—epilepsy syndrome	0.000224	0.00115	CcSEcCtD
Indacaterol—Malnutrition—Valproic Acid—epilepsy syndrome	0.000224	0.00115	CcSEcCtD
Indacaterol—Paraesthesia—Phenytoin—epilepsy syndrome	0.000224	0.00115	CcSEcCtD
Indacaterol—Dyspnoea—Clonazepam—epilepsy syndrome	0.000224	0.00115	CcSEcCtD
Indacaterol—Sinusitis—Gabapentin—epilepsy syndrome	0.000223	0.00114	CcSEcCtD
Indacaterol—Dyspnoea—Phenytoin—epilepsy syndrome	0.000222	0.00114	CcSEcCtD
Indacaterol—Hypersensitivity—Midazolam—epilepsy syndrome	0.000222	0.00114	CcSEcCtD
Indacaterol—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000221	0.00114	CcSEcCtD
Indacaterol—Nausea—Clobazam—epilepsy syndrome	0.000221	0.00113	CcSEcCtD
Indacaterol—Dizziness—Acetazolamide—epilepsy syndrome	0.000219	0.00112	CcSEcCtD
Indacaterol—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000219	0.00112	CcSEcCtD
Indacaterol—Angina pectoris—Topiramate—epilepsy syndrome	0.000219	0.00112	CcSEcCtD
Indacaterol—Pruritus—Propofol—epilepsy syndrome	0.000218	0.00112	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000217	0.00111	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000217	0.00111	CcSEcCtD
Indacaterol—Cardiac disorder—Pregabalin—epilepsy syndrome	0.000216	0.00111	CcSEcCtD
Indacaterol—Muscle spasms—Valproic Acid—epilepsy syndrome	0.000216	0.00111	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000215	0.00111	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000214	0.0011	CcSEcCtD
Indacaterol—Paraesthesia—Carbamazepine—epilepsy syndrome	0.000214	0.0011	CcSEcCtD
Indacaterol—Pruritus—Midazolam—epilepsy syndrome	0.000213	0.00109	CcSEcCtD
Indacaterol—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000212	0.00109	CcSEcCtD
Indacaterol—Oedema peripheral—Gabapentin—epilepsy syndrome	0.00021	0.00108	CcSEcCtD
Indacaterol—Immune system disorder—Pregabalin—epilepsy syndrome	0.00021	0.00108	CcSEcCtD
Indacaterol—Pruritus—Levetiracetam—epilepsy syndrome	0.00021	0.00108	CcSEcCtD
Indacaterol—Tremor—Valproic Acid—epilepsy syndrome	0.00021	0.00108	CcSEcCtD
Indacaterol—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.00021	0.00108	CcSEcCtD
Indacaterol—Connective tissue disorder—Gabapentin—epilepsy syndrome	0.00021	0.00108	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.00021	0.00108	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Topiramate—epilepsy syndrome	0.000209	0.00107	CcSEcCtD
Indacaterol—Headache—Acetazolamide—epilepsy syndrome	0.000207	0.00106	CcSEcCtD
Indacaterol—Anaemia—Valproic Acid—epilepsy syndrome	0.000207	0.00106	CcSEcCtD
Indacaterol—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000207	0.00106	CcSEcCtD
Indacaterol—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000206	0.00106	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000206	0.00105	CcSEcCtD
Indacaterol—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000205	0.00105	CcSEcCtD
Indacaterol—Dizziness—Propofol—epilepsy syndrome	0.000203	0.00104	CcSEcCtD
Indacaterol—Pruritus—Fosphenytoin—epilepsy syndrome	0.000203	0.00104	CcSEcCtD
Indacaterol—Hypersensitivity—Diazepam—epilepsy syndrome	0.000203	0.00104	CcSEcCtD
Indacaterol—Malnutrition—Pregabalin—epilepsy syndrome	0.000203	0.00104	CcSEcCtD
Indacaterol—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000202	0.00104	CcSEcCtD
Indacaterol—Vertigo—Valproic Acid—epilepsy syndrome	0.000201	0.00103	CcSEcCtD
Indacaterol—Pneumonia—Topiramate—epilepsy syndrome	0.000201	0.00103	CcSEcCtD
Indacaterol—Infestation NOS—Topiramate—epilepsy syndrome	0.0002	0.00103	CcSEcCtD
Indacaterol—Infestation—Topiramate—epilepsy syndrome	0.0002	0.00103	CcSEcCtD
Indacaterol—Dizziness—Midazolam—epilepsy syndrome	0.000199	0.00102	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000199	0.00102	CcSEcCtD
Indacaterol—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000198	0.00102	CcSEcCtD
Indacaterol—Palpitations—Valproic Acid—epilepsy syndrome	0.000198	0.00102	CcSEcCtD
Indacaterol—Pruritus—Vigabatrin—epilepsy syndrome	0.000198	0.00101	CcSEcCtD
Indacaterol—Nausea—Acetazolamide—epilepsy syndrome	0.000197	0.00101	CcSEcCtD
Indacaterol—Dizziness—Levetiracetam—epilepsy syndrome	0.000196	0.00101	CcSEcCtD
Indacaterol—Cough—Valproic Acid—epilepsy syndrome	0.000196	0.001	CcSEcCtD
Indacaterol—Muscle spasms—Pregabalin—epilepsy syndrome	0.000195	0.000999	CcSEcCtD
Indacaterol—Pruritus—Diazepam—epilepsy syndrome	0.000195	0.000998	CcSEcCtD
Indacaterol—Rash—Propofol—epilepsy syndrome	0.000194	0.000994	CcSEcCtD
Indacaterol—Dermatitis—Propofol—epilepsy syndrome	0.000194	0.000994	CcSEcCtD
Indacaterol—Immune system disorder—Gabapentin—epilepsy syndrome	0.000193	0.000989	CcSEcCtD
Indacaterol—Headache—Propofol—epilepsy syndrome	0.000193	0.000988	CcSEcCtD
Indacaterol—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000192	0.000987	CcSEcCtD
Indacaterol—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000192	0.000985	CcSEcCtD
Indacaterol—Chest pain—Valproic Acid—epilepsy syndrome	0.000191	0.000979	CcSEcCtD
Indacaterol—Myalgia—Valproic Acid—epilepsy syndrome	0.000191	0.000979	CcSEcCtD
Indacaterol—Tremor—Pregabalin—epilepsy syndrome	0.00019	0.000974	CcSEcCtD
Indacaterol—Rash—Midazolam—epilepsy syndrome	0.00019	0.000973	CcSEcCtD
Indacaterol—Dizziness—Fosphenytoin—epilepsy syndrome	0.00019	0.000973	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.00019	0.000972	CcSEcCtD
Indacaterol—Dermatitis—Midazolam—epilepsy syndrome	0.00019	0.000972	CcSEcCtD
Indacaterol—Headache—Midazolam—epilepsy syndrome	0.000188	0.000967	CcSEcCtD
Indacaterol—Pruritus—Felbamate—epilepsy syndrome	0.000188	0.000966	CcSEcCtD
Indacaterol—Sinusitis—Topiramate—epilepsy syndrome	0.000188	0.000963	CcSEcCtD
Indacaterol—Rash—Levetiracetam—epilepsy syndrome	0.000187	0.000961	CcSEcCtD
Indacaterol—Anaemia—Pregabalin—epilepsy syndrome	0.000187	0.000961	CcSEcCtD
Indacaterol—Dermatitis—Levetiracetam—epilepsy syndrome	0.000187	0.00096	CcSEcCtD
Indacaterol—Dry mouth—Valproic Acid—epilepsy syndrome	0.000187	0.000957	CcSEcCtD
Indacaterol—Headache—Levetiracetam—epilepsy syndrome	0.000186	0.000955	CcSEcCtD
Indacaterol—Malnutrition—Gabapentin—epilepsy syndrome	0.000186	0.000953	CcSEcCtD
Indacaterol—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000185	0.000949	CcSEcCtD
Indacaterol—Dizziness—Vigabatrin—epilepsy syndrome	0.000185	0.000948	CcSEcCtD
Indacaterol—Pruritus—Zonisamide—epilepsy syndrome	0.000184	0.000946	CcSEcCtD
Indacaterol—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000184	0.000943	CcSEcCtD
Indacaterol—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000183	0.000938	CcSEcCtD
Indacaterol—Nausea—Propofol—epilepsy syndrome	0.000183	0.000937	CcSEcCtD
Indacaterol—Vertigo—Pregabalin—epilepsy syndrome	0.000182	0.000934	CcSEcCtD
Indacaterol—Dizziness—Diazepam—epilepsy syndrome	0.000182	0.000933	CcSEcCtD
Indacaterol—Infection—Valproic Acid—epilepsy syndrome	0.000182	0.000932	CcSEcCtD
Indacaterol—Rash—Fosphenytoin—epilepsy syndrome	0.000181	0.000927	CcSEcCtD
Indacaterol—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000181	0.000926	CcSEcCtD
Indacaterol—Headache—Fosphenytoin—epilepsy syndrome	0.00018	0.000921	CcSEcCtD
Indacaterol—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000179	0.00092	CcSEcCtD
Indacaterol—Palpitations—Pregabalin—epilepsy syndrome	0.000179	0.000919	CcSEcCtD
Indacaterol—Nausea—Midazolam—epilepsy syndrome	0.000179	0.000917	CcSEcCtD
Indacaterol—Muscle spasms—Gabapentin—epilepsy syndrome	0.000179	0.000916	CcSEcCtD
Indacaterol—Tachycardia—Valproic Acid—epilepsy syndrome	0.000179	0.000916	CcSEcCtD
Indacaterol—Pruritus—Clonazepam—epilepsy syndrome	0.000178	0.000912	CcSEcCtD
Indacaterol—Skin disorder—Valproic Acid—epilepsy syndrome	0.000178	0.000911	CcSEcCtD
Indacaterol—Oedema peripheral—Topiramate—epilepsy syndrome	0.000177	0.000907	CcSEcCtD
Indacaterol—Cough—Pregabalin—epilepsy syndrome	0.000177	0.000907	CcSEcCtD
Indacaterol—Pruritus—Phenytoin—epilepsy syndrome	0.000177	0.000906	CcSEcCtD
Indacaterol—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000176	0.000905	CcSEcCtD
Indacaterol—Nausea—Levetiracetam—epilepsy syndrome	0.000176	0.000905	CcSEcCtD
Indacaterol—Rash—Vigabatrin—epilepsy syndrome	0.000176	0.000904	CcSEcCtD
Indacaterol—Dizziness—Felbamate—epilepsy syndrome	0.000176	0.000903	CcSEcCtD
Indacaterol—Dermatitis—Vigabatrin—epilepsy syndrome	0.000176	0.000903	CcSEcCtD
Indacaterol—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000176	0.000901	CcSEcCtD
Indacaterol—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000176	0.0009	CcSEcCtD
Indacaterol—Headache—Vigabatrin—epilepsy syndrome	0.000175	0.000898	CcSEcCtD
Indacaterol—Tremor—Gabapentin—epilepsy syndrome	0.000174	0.000893	CcSEcCtD
Indacaterol—Rash—Diazepam—epilepsy syndrome	0.000173	0.00089	CcSEcCtD
Indacaterol—Dermatitis—Diazepam—epilepsy syndrome	0.000173	0.000889	CcSEcCtD
Indacaterol—Myalgia—Pregabalin—epilepsy syndrome	0.000173	0.000885	CcSEcCtD
Indacaterol—Chest pain—Pregabalin—epilepsy syndrome	0.000173	0.000885	CcSEcCtD
Indacaterol—Dizziness—Zonisamide—epilepsy syndrome	0.000172	0.000884	CcSEcCtD
Indacaterol—Headache—Diazepam—epilepsy syndrome	0.000172	0.000884	CcSEcCtD
Indacaterol—Anaemia—Gabapentin—epilepsy syndrome	0.000172	0.000881	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000171	0.000879	CcSEcCtD
Indacaterol—Nausea—Fosphenytoin—epilepsy syndrome	0.00017	0.000874	CcSEcCtD
Indacaterol—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.00017	0.00087	CcSEcCtD
Indacaterol—Dry mouth—Pregabalin—epilepsy syndrome	0.000169	0.000865	CcSEcCtD
Indacaterol—Pruritus—Carbamazepine—epilepsy syndrome	0.000169	0.000864	CcSEcCtD
Indacaterol—Rash—Felbamate—epilepsy syndrome	0.000168	0.000861	CcSEcCtD
Indacaterol—Dermatitis—Felbamate—epilepsy syndrome	0.000168	0.00086	CcSEcCtD
Indacaterol—Vertigo—Gabapentin—epilepsy syndrome	0.000167	0.000856	CcSEcCtD
Indacaterol—Headache—Felbamate—epilepsy syndrome	0.000167	0.000856	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000167	0.000855	CcSEcCtD
Indacaterol—Cardiac disorder—Topiramate—epilepsy syndrome	0.000167	0.000855	CcSEcCtD
Indacaterol—Dizziness—Clonazepam—epilepsy syndrome	0.000166	0.000852	CcSEcCtD
Indacaterol—Nausea—Vigabatrin—epilepsy syndrome	0.000166	0.000851	CcSEcCtD
Indacaterol—Dizziness—Phenytoin—epilepsy syndrome	0.000165	0.000846	CcSEcCtD
Indacaterol—Rash—Zonisamide—epilepsy syndrome	0.000164	0.000843	CcSEcCtD
Indacaterol—Infection—Pregabalin—epilepsy syndrome	0.000164	0.000843	CcSEcCtD
Indacaterol—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000164	0.000843	CcSEcCtD
Indacaterol—Palpitations—Gabapentin—epilepsy syndrome	0.000164	0.000842	CcSEcCtD
Indacaterol—Dermatitis—Zonisamide—epilepsy syndrome	0.000164	0.000842	CcSEcCtD
Indacaterol—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000164	0.000842	CcSEcCtD
Indacaterol—Nausea—Diazepam—epilepsy syndrome	0.000163	0.000838	CcSEcCtD
Indacaterol—Headache—Zonisamide—epilepsy syndrome	0.000163	0.000838	CcSEcCtD
Indacaterol—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000163	0.000837	CcSEcCtD
Indacaterol—Pruritus—Lamotrigine—epilepsy syndrome	0.000163	0.000835	CcSEcCtD
Indacaterol—Immune system disorder—Topiramate—epilepsy syndrome	0.000162	0.000832	CcSEcCtD
Indacaterol—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000162	0.000832	CcSEcCtD
Indacaterol—Cough—Gabapentin—epilepsy syndrome	0.000162	0.000832	CcSEcCtD
Indacaterol—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000162	0.00083	CcSEcCtD
Indacaterol—Tachycardia—Pregabalin—epilepsy syndrome	0.000161	0.000828	CcSEcCtD
Indacaterol—Skin disorder—Pregabalin—epilepsy syndrome	0.000161	0.000824	CcSEcCtD
Indacaterol—Rash—Clonazepam—epilepsy syndrome	0.000158	0.000812	CcSEcCtD
Indacaterol—Dermatitis—Clonazepam—epilepsy syndrome	0.000158	0.000812	CcSEcCtD
Indacaterol—Myalgia—Gabapentin—epilepsy syndrome	0.000158	0.000811	CcSEcCtD
Indacaterol—Chest pain—Gabapentin—epilepsy syndrome	0.000158	0.000811	CcSEcCtD
Indacaterol—Nausea—Felbamate—epilepsy syndrome	0.000158	0.000811	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000158	0.00081	CcSEcCtD
Indacaterol—Dizziness—Carbamazepine—epilepsy syndrome	0.000158	0.000808	CcSEcCtD
Indacaterol—Headache—Clonazepam—epilepsy syndrome	0.000157	0.000807	CcSEcCtD
Indacaterol—Rash—Phenytoin—epilepsy syndrome	0.000157	0.000807	CcSEcCtD
Indacaterol—Dermatitis—Phenytoin—epilepsy syndrome	0.000157	0.000806	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000157	0.000806	CcSEcCtD
Indacaterol—Rash—Oxcarbazepine—epilepsy syndrome	0.000157	0.000803	CcSEcCtD
Indacaterol—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000156	0.000802	CcSEcCtD
Indacaterol—Headache—Phenytoin—epilepsy syndrome	0.000156	0.000802	CcSEcCtD
Indacaterol—Malnutrition—Topiramate—epilepsy syndrome	0.000156	0.000802	CcSEcCtD
Indacaterol—Headache—Oxcarbazepine—epilepsy syndrome	0.000156	0.000798	CcSEcCtD
Indacaterol—Nausea—Zonisamide—epilepsy syndrome	0.000155	0.000794	CcSEcCtD
Indacaterol—Dry mouth—Gabapentin—epilepsy syndrome	0.000155	0.000794	CcSEcCtD
Indacaterol—Dizziness—Lamotrigine—epilepsy syndrome	0.000152	0.000781	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000151	0.000773	CcSEcCtD
Indacaterol—Infection—Gabapentin—epilepsy syndrome	0.000151	0.000773	CcSEcCtD
Indacaterol—Muscle spasms—Topiramate—epilepsy syndrome	0.00015	0.000771	CcSEcCtD
Indacaterol—Rash—Carbamazepine—epilepsy syndrome	0.00015	0.00077	CcSEcCtD
Indacaterol—Dermatitis—Carbamazepine—epilepsy syndrome	0.00015	0.00077	CcSEcCtD
Indacaterol—Nausea—Clonazepam—epilepsy syndrome	0.000149	0.000765	CcSEcCtD
Indacaterol—Headache—Carbamazepine—epilepsy syndrome	0.000149	0.000765	CcSEcCtD
Indacaterol—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000149	0.000763	CcSEcCtD
Indacaterol—Paraesthesia—Pregabalin—epilepsy syndrome	0.000149	0.000762	CcSEcCtD
Indacaterol—Nausea—Phenytoin—epilepsy syndrome	0.000148	0.00076	CcSEcCtD
Indacaterol—Tachycardia—Gabapentin—epilepsy syndrome	0.000148	0.000759	CcSEcCtD
Indacaterol—Dyspnoea—Pregabalin—epilepsy syndrome	0.000147	0.000756	CcSEcCtD
Indacaterol—Nausea—Oxcarbazepine—epilepsy syndrome	0.000147	0.000756	CcSEcCtD
Indacaterol—Skin disorder—Gabapentin—epilepsy syndrome	0.000147	0.000756	CcSEcCtD
Indacaterol—Tremor—Topiramate—epilepsy syndrome	0.000146	0.000751	CcSEcCtD
Indacaterol—Rash—Lamotrigine—epilepsy syndrome	0.000145	0.000745	CcSEcCtD
Indacaterol—Dermatitis—Lamotrigine—epilepsy syndrome	0.000145	0.000744	CcSEcCtD
Indacaterol—Anaemia—Topiramate—epilepsy syndrome	0.000145	0.000741	CcSEcCtD
Indacaterol—Headache—Lamotrigine—epilepsy syndrome	0.000144	0.00074	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000143	0.000732	CcSEcCtD
Indacaterol—Nausea—Carbamazepine—epilepsy syndrome	0.000141	0.000726	CcSEcCtD
Indacaterol—Vertigo—Topiramate—epilepsy syndrome	0.00014	0.00072	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000138	0.000709	CcSEcCtD
Indacaterol—Palpitations—Topiramate—epilepsy syndrome	0.000138	0.000709	CcSEcCtD
Indacaterol—Nausea—Lamotrigine—epilepsy syndrome	0.000137	0.000701	CcSEcCtD
Indacaterol—Cough—Topiramate—epilepsy syndrome	0.000136	0.0007	CcSEcCtD
Indacaterol—Paraesthesia—Gabapentin—epilepsy syndrome	0.000136	0.000698	CcSEcCtD
Indacaterol—Dyspnoea—Gabapentin—epilepsy syndrome	0.000135	0.000693	CcSEcCtD
Indacaterol—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000135	0.000691	CcSEcCtD
Indacaterol—Chest pain—Topiramate—epilepsy syndrome	0.000133	0.000683	CcSEcCtD
Indacaterol—Myalgia—Topiramate—epilepsy syndrome	0.000133	0.000683	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000132	0.000678	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000131	0.000672	CcSEcCtD
Indacaterol—Dry mouth—Topiramate—epilepsy syndrome	0.00013	0.000668	CcSEcCtD
Indacaterol—Pruritus—Valproic Acid—epilepsy syndrome	0.000129	0.000664	CcSEcCtD
Indacaterol—Infection—Topiramate—epilepsy syndrome	0.000127	0.00065	CcSEcCtD
Indacaterol—Nervous system disorder—Topiramate—epilepsy syndrome	0.000125	0.000642	CcSEcCtD
Indacaterol—Tachycardia—Topiramate—epilepsy syndrome	0.000125	0.000639	CcSEcCtD
Indacaterol—Skin disorder—Topiramate—epilepsy syndrome	0.000124	0.000636	CcSEcCtD
Indacaterol—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000122	0.000625	CcSEcCtD
Indacaterol—Dizziness—Valproic Acid—epilepsy syndrome	0.000121	0.00062	CcSEcCtD
Indacaterol—Pruritus—Pregabalin—epilepsy syndrome	0.000117	0.0006	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000116	0.000596	CcSEcCtD
Indacaterol—Rash—Valproic Acid—epilepsy syndrome	0.000115	0.000592	CcSEcCtD
Indacaterol—Dermatitis—Valproic Acid—epilepsy syndrome	0.000115	0.000591	CcSEcCtD
Indacaterol—Headache—Valproic Acid—epilepsy syndrome	0.000115	0.000588	CcSEcCtD
Indacaterol—Paraesthesia—Topiramate—epilepsy syndrome	0.000115	0.000588	CcSEcCtD
Indacaterol—Dyspnoea—Topiramate—epilepsy syndrome	0.000114	0.000583	CcSEcCtD
Indacaterol—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000112	0.000573	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.00011	0.000565	CcSEcCtD
Indacaterol—Dizziness—Pregabalin—epilepsy syndrome	0.000109	0.000561	CcSEcCtD
Indacaterol—Nausea—Valproic Acid—epilepsy syndrome	0.000109	0.000557	CcSEcCtD
Indacaterol—Pruritus—Gabapentin—epilepsy syndrome	0.000107	0.00055	CcSEcCtD
Indacaterol—Rash—Pregabalin—epilepsy syndrome	0.000104	0.000535	CcSEcCtD
Indacaterol—Dermatitis—Pregabalin—epilepsy syndrome	0.000104	0.000534	CcSEcCtD
Indacaterol—Headache—Pregabalin—epilepsy syndrome	0.000104	0.000531	CcSEcCtD
Indacaterol—Dizziness—Gabapentin—epilepsy syndrome	0.0001	0.000514	CcSEcCtD
Indacaterol—Nausea—Pregabalin—epilepsy syndrome	9.82e-05	0.000504	CcSEcCtD
Indacaterol—Rash—Gabapentin—epilepsy syndrome	9.56e-05	0.00049	CcSEcCtD
Indacaterol—Dermatitis—Gabapentin—epilepsy syndrome	9.55e-05	0.00049	CcSEcCtD
Indacaterol—Headache—Gabapentin—epilepsy syndrome	9.5e-05	0.000487	CcSEcCtD
Indacaterol—Hypersensitivity—Topiramate—epilepsy syndrome	9.4e-05	0.000482	CcSEcCtD
Indacaterol—Pruritus—Topiramate—epilepsy syndrome	9.03e-05	0.000463	CcSEcCtD
Indacaterol—Nausea—Gabapentin—epilepsy syndrome	9.01e-05	0.000462	CcSEcCtD
Indacaterol—Dizziness—Topiramate—epilepsy syndrome	8.44e-05	0.000433	CcSEcCtD
Indacaterol—Rash—Topiramate—epilepsy syndrome	8.05e-05	0.000413	CcSEcCtD
Indacaterol—Dermatitis—Topiramate—epilepsy syndrome	8.04e-05	0.000412	CcSEcCtD
Indacaterol—Headache—Topiramate—epilepsy syndrome	7.99e-05	0.00041	CcSEcCtD
Indacaterol—Nausea—Topiramate—epilepsy syndrome	7.58e-05	0.000389	CcSEcCtD
Indacaterol—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.72e-05	0.000212	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GABBR1—epilepsy syndrome	1.72e-05	0.000212	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—AVP—epilepsy syndrome	1.71e-05	0.000211	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.69e-05	0.000209	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HRH3—epilepsy syndrome	1.68e-05	0.000208	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—SLC2A1—epilepsy syndrome	1.68e-05	0.000207	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—AVP—epilepsy syndrome	1.67e-05	0.000206	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.66e-05	0.000205	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PLCB1—epilepsy syndrome	1.66e-05	0.000205	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—OPRM1—epilepsy syndrome	1.66e-05	0.000205	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—TH—epilepsy syndrome	1.65e-05	0.000204	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.65e-05	0.000204	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.65e-05	0.000204	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HRH3—epilepsy syndrome	1.65e-05	0.000203	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.64e-05	0.000203	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—OPRM1—epilepsy syndrome	1.62e-05	0.0002	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.62e-05	0.0002	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.62e-05	0.0002	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.62e-05	0.0002	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.62e-05	0.0002	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.61e-05	0.000199	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.6e-05	0.000197	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.57e-05	0.000194	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.57e-05	0.000194	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	1.56e-05	0.000193	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.56e-05	0.000193	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.56e-05	0.000193	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.54e-05	0.00019	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	1.53e-05	0.000189	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.53e-05	0.000189	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	1.52e-05	0.000188	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.52e-05	0.000188	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.51e-05	0.000186	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.5e-05	0.000186	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.5e-05	0.000186	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.5e-05	0.000185	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	1.49e-05	0.000184	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.49e-05	0.000184	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	1.48e-05	0.000183	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.48e-05	0.000183	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	1.47e-05	0.000182	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	1.47e-05	0.000182	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	1.47e-05	0.000182	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	1.47e-05	0.000182	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	1.47e-05	0.000182	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.45e-05	0.000179	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	1.45e-05	0.000179	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	1.45e-05	0.000179	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.44e-05	0.000178	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	1.44e-05	0.000178	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	1.44e-05	0.000178	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	1.44e-05	0.000178	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	1.44e-05	0.000178	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	1.44e-05	0.000178	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.42e-05	0.000175	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	1.42e-05	0.000175	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.41e-05	0.000175	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.41e-05	0.000174	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.39e-05	0.000172	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—HMOX1—epilepsy syndrome	1.38e-05	0.00017	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.37e-05	0.000169	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	1.37e-05	0.000169	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	1.37e-05	0.000169	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CAT—epilepsy syndrome	1.36e-05	0.000168	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.36e-05	0.000168	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.35e-05	0.000167	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	1.35e-05	0.000166	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.34e-05	0.000166	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.34e-05	0.000166	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.34e-05	0.000166	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.34e-05	0.000166	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.34e-05	0.000166	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.34e-05	0.000166	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.34e-05	0.000165	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	1.34e-05	0.000165	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	1.34e-05	0.000165	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	1.33e-05	0.000164	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	1.33e-05	0.000164	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	1.33e-05	0.000164	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ABCB1—epilepsy syndrome	1.32e-05	0.000163	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.32e-05	0.000163	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	1.32e-05	0.000163	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	1.32e-05	0.000163	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.3e-05	0.000161	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	1.3e-05	0.000161	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	1.3e-05	0.000161	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	1.3e-05	0.000161	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	1.3e-05	0.00016	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	1.29e-05	0.000159	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.27e-05	0.000157	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	1.27e-05	0.000157	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	1.25e-05	0.000154	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.25e-05	0.000154	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	1.25e-05	0.000154	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.24e-05	0.000154	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.24e-05	0.000153	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GPX1—epilepsy syndrome	1.23e-05	0.000152	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	1.23e-05	0.000152	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	1.23e-05	0.000152	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.23e-05	0.000152	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.23e-05	0.000152	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.23e-05	0.000152	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	1.22e-05	0.000151	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.22e-05	0.000151	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	1.22e-05	0.000151	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	1.22e-05	0.000151	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.22e-05	0.00015	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.21e-05	0.00015	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.21e-05	0.000149	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	1.2e-05	0.000148	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	1.2e-05	0.000148	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	1.2e-05	0.000148	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	1.2e-05	0.000148	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1.19e-05	0.000147	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1.19e-05	0.000147	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.18e-05	0.000146	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	1.17e-05	0.000145	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	1.16e-05	0.000144	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	1.14e-05	0.000141	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.14e-05	0.000141	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.14e-05	0.000141	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	1.14e-05	0.00014	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	1.13e-05	0.00014	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	1.12e-05	0.000138	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	1.11e-05	0.000138	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	1.11e-05	0.000137	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	1.11e-05	0.000137	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	1.09e-05	0.000135	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	1.09e-05	0.000134	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—AGT—epilepsy syndrome	1.08e-05	0.000133	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.07e-05	0.000132	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—APOE—epilepsy syndrome	1.06e-05	0.000131	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	1.05e-05	0.00013	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	1.04e-05	0.000129	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.04e-05	0.000129	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	1.04e-05	0.000129	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	1.03e-05	0.000127	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	1.02e-05	0.000126	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	1.02e-05	0.000126	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.02e-05	0.000126	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.02e-05	0.000126	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	1.01e-05	0.000124	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	9.86e-06	0.000122	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ABCG2—epilepsy syndrome	9.72e-06	0.00012	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	9.7e-06	0.00012	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	9.7e-06	0.00012	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	9.53e-06	0.000118	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	9.49e-06	0.000117	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	9.48e-06	0.000117	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	9.42e-06	0.000116	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	9.32e-06	0.000115	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ADSL—epilepsy syndrome	9.3e-06	0.000115	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	9.27e-06	0.000114	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	9.23e-06	0.000114	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	9.22e-06	0.000114	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GLUL—epilepsy syndrome	9.12e-06	0.000113	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—POMC—epilepsy syndrome	9.08e-06	0.000112	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	9.07e-06	0.000112	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	9.03e-06	0.000112	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	9.02e-06	0.000111	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	8.98e-06	0.000111	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	8.95e-06	0.000111	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	8.91e-06	0.00011	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	8.81e-06	0.000109	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	8.71e-06	0.000108	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	8.62e-06	0.000106	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	8.57e-06	0.000106	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	8.5e-06	0.000105	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	8.39e-06	0.000104	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	8.38e-06	0.000104	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	8.37e-06	0.000103	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ALB—epilepsy syndrome	8.28e-06	0.000102	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	8.2e-06	0.000101	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—AQP1—epilepsy syndrome	8.13e-06	0.0001	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.1e-06	0.0001	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	8.09e-06	9.99e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—BCHE—epilepsy syndrome	8.06e-06	9.95e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	7.97e-06	9.84e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	7.96e-06	9.83e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	7.8e-06	9.63e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	7.79e-06	9.63e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	7.78e-06	9.61e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	7.69e-06	9.49e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	7.64e-06	9.43e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	7.63e-06	9.42e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PLCB1—epilepsy syndrome	7.6e-06	9.39e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—TH—epilepsy syndrome	7.58e-06	9.36e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	7.47e-06	9.23e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	7.35e-06	9.08e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	7.35e-06	9.08e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	7.35e-06	9.08e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	7.32e-06	9.05e-05	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTGS2—epilepsy syndrome	7.24e-06	8.94e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	7.19e-06	8.88e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	7.16e-06	8.85e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	6.7e-06	8.27e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	6.55e-06	8.09e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	6.55e-06	8.09e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	6.41e-06	7.92e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—HMOX1—epilepsy syndrome	6.32e-06	7.81e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CAT—epilepsy syndrome	6.24e-06	7.71e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	5.99e-06	7.4e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	5.92e-06	7.32e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	5.84e-06	7.21e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	5.8e-06	7.17e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	5.79e-06	7.16e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GPX1—epilepsy syndrome	5.64e-06	6.97e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	5.5e-06	6.79e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	5.39e-06	6.66e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	5.38e-06	6.64e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	5.27e-06	6.51e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	5.24e-06	6.47e-05	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	5e-06	6.18e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	4.98e-06	6.16e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—BCHE—epilepsy syndrome	4.96e-06	6.13e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	4.96e-06	6.13e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—AGT—epilepsy syndrome	4.95e-06	6.11e-05	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	4.9e-06	6.05e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	4.85e-06	5.99e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—APOE—epilepsy syndrome	4.85e-06	5.99e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	4.82e-06	5.95e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	4.74e-06	5.85e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	4.71e-06	5.82e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	4.69e-06	5.79e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	4.68e-06	5.79e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—TH—epilepsy syndrome	4.67e-06	5.76e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	4.58e-06	5.66e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	4.54e-06	5.61e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	4.45e-06	5.49e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	4.32e-06	5.34e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	4.23e-06	5.22e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	4.21e-06	5.2e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—POMC—epilepsy syndrome	4.16e-06	5.14e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	4.12e-06	5.08e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.9e-06	4.81e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.84e-06	4.75e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALB—epilepsy syndrome	3.8e-06	4.69e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.74e-06	4.62e-05	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—AKT1—epilepsy syndrome	3.64e-06	4.49e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.48e-06	4.29e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTGS2—epilepsy syndrome	3.32e-06	4.1e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.05e-06	3.76e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.99e-06	3.69e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	2.68e-06	3.32e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	2.63e-06	3.24e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.57e-06	3.17e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.34e-06	2.89e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.05e-06	2.53e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.67e-06	2.06e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.03e-06	1.27e-05	CbGpPWpGaD
